Novartis target started at CHF120 by RBC
RBC started coverage with a CHF120 target for Novartis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
RBC started coverage with a CHF120 target for Novartis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.